Literature DB >> 25427683

Safety and clinical outcome in combination therapy for high-risk elderly hypertensive patients.

Seiji Umemoto1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25427683     DOI： 10.1038/hr.2014.166

Source DB:  PubMed          Journal:  Hypertens Res        ISSN： 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  15 in total

1.  Combination therapy for hypertension in the elderly: a sub-analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial.

Authors:  Toshio Ogihara; Masunori Matsuzaki; Seiji Umemoto; Hiromi Rakugi; Hiroaki Matsuoka; Kazuyuki Shimada; Jitsuo Higaki; Sadayoshi Ito; Akira Kamiya; Hiromichi Suzuki; Yasuo Ohashi; Kazuaki Shimamoto; Takao Saruta
Journal:  Hypertens Res       Date:  2012-01-26       Impact factor: 3.872

2.  The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014).

Authors:  Kazuaki Shimamoto; Katsuyuki Ando; Toshiro Fujita; Naoyuki Hasebe; Jitsuo Higaki; Masatsugu Horiuchi; Yutaka Imai; Tsutomu Imaizumi; Toshihiko Ishimitsu; Masaaki Ito; Sadayoshi Ito; Hiroshi Itoh; Hiroshi Iwao; Hisashi Kai; Kazuomi Kario; Naoki Kashihara; Yuhei Kawano; Shokei Kim-Mitsuyama; Genjiro Kimura; Katsuhiko Kohara; Issei Komuro; Hiroo Kumagai; Hideo Matsuura; Katsuyuki Miura; Ryuichi Morishita; Mitsuhide Naruse; Koichi Node; Yusuke Ohya; Hiromi Rakugi; Ikuo Saito; Shigeyuki Saitoh; Kazuyuki Shimada; Tatsuo Shimosawa; Hiromichi Suzuki; Kouichi Tamura; Norio Tanahashi; Takuya Tsuchihashi; Makoto Uchiyama; Shinichiro Ueda; Satoshi Umemura
Journal:  Hypertens Res       Date:  2014-04       Impact factor: 3.872

3.  Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients.

Authors:  Hisao Ogawa; Shokei Kim-Mitsuyama; Kunihiko Matsui; Tomio Jinnouchi; Hideaki Jinnouchi; Kikuo Arakawa
Journal:  Am J Med       Date:  2012-04-14       Impact factor: 4.965

4.  Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials.

Authors:  David S Wald; Malcolm Law; Joan K Morris; Jonathan P Bestwick; Nicholas J Wald
Journal:  Am J Med       Date:  2009-03       Impact factor: 4.965

5.  Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients.

Authors:  Sukyoun Shin; Hyunjong Song; Sang-Kwon Oh; Kyung Eob Choi; Ho Kim; Sunmee Jang
Journal:  Hypertens Res       Date:  2013-08-22       Impact factor: 3.872

Review 6.  Salt sensitivity of Japanese from the viewpoint of gene polymorphism.

Authors:  Tomohiro Katsuya; Kazuhiko Ishikawa; Ken Sugimoto; Hiromi Rakugi; Toshio Ogihara
Journal:  Hypertens Res       Date:  2003-07       Impact factor: 3.872

7.  Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials.

Authors:  M R Law; N J Wald; J K Morris; R E Jordan
Journal:  BMJ       Date:  2003-06-28

8.  Comparison of olmesartan combined with a calcium channel blocker or a diuretic in elderly hypertensive patients (COLM Study): safety and tolerability.

Authors:  Takao Saruta; Toshio Ogihara; Ikuo Saito; Hiromi Rakugi; Kazuaki Shimamoto; Hiroaki Matsuoka; Satoshi Teramukai; Jitsuo Higaki; Sadayoshi Ito; Kazuyuki Shimada
Journal:  Hypertens Res       Date:  2014-09-25       Impact factor: 3.872

9.  Biased safety reporting in blinded randomized clinical trials: meta-analysis of angiotensin receptor blocker trials.

Authors:  Nobuyoshi Takabayashi; Hisashi Urushihara; Koji Kawakami
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

10.  Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial.

Authors:  Toshio Ogihara; Takao Saruta; Hiromi Rakugi; Ikuo Saito; Kazuaki Shimamoto; Hiroaki Matsuoka; Kazuyuki Shimada; Sadayoshi Ito; Masatsugu Horiuchi; Tsutomu Imaizumi; Shuichi Takishita; Jitsuo Higaki; Shigehiro Katayama; Genjiroh Kimura; Satoshi Umemura; Nobuyuki Ura; Koichi Hayashi; Masato Odawara; Norio Tanahashi; Toshihiko Ishimitsu; Naoki Kashihara; Satoshi Morita; Satoshi Teramukai
Journal:  J Hypertens       Date:  2014-10       Impact factor: 4.844
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.